Breast Fibrosis
Understand breast fibrosis, also known as fibrosclerosis of the breast or fibrocystic breast disease, with this guide for healthcare professionals. Learn about diagnosis, clinical documentation, and medical coding for breast fibrosis, including ICD-10 codes and relevant terminology for accurate medical records and billing. This resource provides information on breast fibrosis symptoms, treatment, and management strategies for improved patient care.
Benign breast condition marked by excess fibrous tissue, cysts, and discomfort.
Breast lumps, pain tenderness, swelling (often cyclical), nipple discharge.
Primary care, breast clinics, diagnostic imaging centers.
ICD-10 Code Families
Complete code families applicable to N60.39
When to use each related code
| Description | When to use |
|---|---|
| Benign breast changes with fibrous tissue and cysts. | Code B for palpable breast lumps, pain, or nipple discharge related to hormonal changes. Consider alternate names. |
| Non-cancerous breast tumor composed of glandular and fibrous tissue. | Code for solitary, well-circumscribed breast lump. Rule out cancer with biopsy. Often presents in younger women. |
| Ductal dilation and periductal mastitis causing nipple discharge and inflammation. | Code for non-puerperal nipple discharge (sticky, green or brown), periareolar inflammation, or recurrent breast abscess. |
Best-practice checklist
- ✓Document palpable breast mass characteristics (size, location, mobility).
- ✓Note presence/absence of nipple discharge, skin changes, or lymphadenopathy.
- ✓Record patient's age, menstrual history, and family history of breast cancer.
- ✓Include imaging findings (mammogram, ultrasound, MRI) with BIRADS category.
- ✓If biopsy performed, document procedure and pathology results.
Common pitfalls to avoid
Confusing fibrosis (N60.89) with specific fibrocystic changes (N60.1X) like cysts or adenosis. Coding requires detailed documentation.
Failing to document laterality (right, left, bilateral) for breast fibrosis leads to coding errors and claim denials.
Coding breast fibrosis without definitive diagnostic confirmation (e.g., biopsy) may lead to inaccurate reporting and audits.
Best-practice tips
- 01Regular self-exams, clinical breast exams, and mammograms for early detection.
- 02Manage pain with OTC analgesics. Consult physician for severe pain.
- 03Supportive bra, limit caffeine/salt intake, and healthy lifestyle.
- 04Accurate ICD-10 coding (N60.1) for proper reimbursement and data analysis.
- 05CDI: Clear documentation of symptoms, findings, and management for compliance.
Step-by-step checklist
- 1
Confirm palpable breast lump or mammographic density
- 2
Assess for cyclical breast pain, tenderness
- 3
Evaluate family history of breast cancer
- 4
Rule out other breast conditions via imaging, biopsy if needed
- 5
Document ICD-10 N60.89, clinical findings, management plan
Ready-to-paste narrative
Patient presents with complaints consistent with breast fibrosis, also known as fibrocystic breast changes or fibrosclerosis of the breast. Symptoms include breast pain (mastalgia), tenderness, and palpable lumps or thickening, often fluctuating with the menstrual cycle. Physical examination reveals nodularity, rope-like texture, and possible mobile masses within the breast tissue. No nipple discharge or skin changes were observed. Patient reports a family history of benign breast conditions. Differential diagnoses considered include cyclical mastalgia, fibroadenoma, and breast cysts. Mammography and breast ultrasound were ordered to evaluate the breast tissue and rule out malignancy. Based on clinical findings and imaging results, a diagnosis of breast fibrosis was made. The patient was reassured about the benign nature of the condition and educated on breast self-examination. Management includes conservative measures such as supportive bra, over-the-counter pain relievers (NSAIDs), and lifestyle modifications. Follow-up is recommended to monitor symptom progression and assess treatment efficacy. Patient education materials on breast fibrosis and its management were provided. ICD-10 code N60.89 (other specified disorders of breast) and CPT codes for the evaluation and management visit (e.g., 99203-99205 or 99212-99215) will be used for billing and coding purposes.
Common questions and answers
How to differentiate between breast fibrosis and breast cancer during clinical breast examination and imaging?+
Differentiating breast fibrosis from breast cancer can be challenging, as both can present with palpable lumps or abnormalities on imaging. During clinical breast examination, fibrosis often presents as diffuse nodularity or firmness, sometimes described as 'ropy' or 'cord-like,' often bilateral and changing with the menstrual cycle. Cancerous lesions tend to be more distinct, solitary, hard, immobile, and with irregular borders. Mammography may reveal increased density in fibrosis, while cancer may present as spiculated masses, microcalcifications, or architectural distortion. Ultrasound can help differentiate cystic changes often associated with fibrosis from solid masses suspicious for cancer. When differentiation is difficult, further investigation with core needle biopsy or excisional biopsy is warranted to obtain a definitive diagnosis. Consider implementing a standardized approach to breast assessment including detailed patient history, thorough clinical examination, and appropriate imaging studies to ensure accurate differentiation and prompt management. Explore how S10.AI can support clinical decision-making in breast health.
What are the evidence-based management strategies for symptomatic breast fibrosis, including pain and discomfort?+
Management of symptomatic breast fibrosis focuses on alleviating pain and discomfort. Evidence-based strategies include lifestyle modifications, such as wearing supportive bras, reducing caffeine and salt intake, and managing stress. Over-the-counter pain relievers like NSAIDs can be helpful. For some women, evening primrose oil or vitamin E supplementation may offer relief, although evidence is less robust. Hormonal therapy, such as oral contraceptives or selective estrogen receptor modulators (SERMs), may be considered for severe cases, but should be discussed with patients, weighing benefits and risks. It is important to emphasize that fibrocystic changes are generally benign and do not increase the risk of breast cancer. Providing patients with clear information and reassurance can significantly improve their quality of life. Learn more about the latest research on managing breast pain associated with fibrosis.
When should I refer a patient with breast fibrosis for biopsy, considering factors like age, family history, and imaging findings?+
Referral for biopsy is crucial when clinical or imaging findings raise suspicion for malignancy. While breast fibrosis itself is benign, it can coexist with breast cancer, making accurate assessment essential. Factors warranting biopsy include a new dominant mass, rapid growth, focal asymmetry, skin changes (e.g., dimpling, retraction), suspicious imaging features like spiculated masses or microcalcifications, and a strong family history of breast cancer. Age is also a factor; while fibrosis is common in younger women, the likelihood of malignancy increases with age. A palpable lump that persists despite a negative mammogram or ultrasound also requires further investigation. A fine-needle aspiration may not be sufficient to rule out malignancy in these cases, and a core needle biopsy is usually preferred to provide adequate tissue for histological analysis. Explore how S10.AI can support diagnostic accuracy and personalized patient management in breast health.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.